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Abstract 
The 2016 presidential election had important implications for the country’s health care 
policies. In this study, we examine the health care industry stock returns associated with the 
2016 presidential campaign. We use both market model and seemingly unrelated regression 
(SUR) methodologies to estimate abnormal stock returns of each health care sector associated 
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with each event. Our results are robust and mostly consistent with our arguments. The 
regression analysis further augments our event study results. We find that, during the 
pre-election period, the Biological Products, Health Insurance, and Major Pharmaceuticals all 
suffer significantly negative cumulative average abnormal returns (CAARs). The 
Hospital/Nursing Management and Medical/Dental Instruments fare reasonably well. Our 
interpretation is that the market takes a dim view on the Biological Products, Health Insurance, 
and Major Pharmaceuticals sectors when the consensus is that Clinton would win the election. 
When the election is over, the fortune reverses for the Biological Products and Major 
Pharmaceuticals. It continues when President Trump meets with the health care industry CEOs. 
The regression results further confirm our event study results. Our study shows that the 2016 
election has a significant impact on the affected industry and the firms in the industry. However, 
even in the same broad industry, sectors/firms fare differently. Our study shows that it is 
important to identify the winning and losing sectors and examine the impact of an election on 
various sectors in a detailed and refined way.  
Keywords: 2016 Campaign, 2016 Election, Health care industry, Event studies 
1. Introduction 
Repealing Obamacare became Trump’s signature promise during his campaign trail. He 
continued making that promise when he became the presumptive Republican candidate and 
the President. As a candidate, president-elect, and president, Trump has repeatedly pointed to 
the repeal of Obamacare as a top priority and a key reason why he wanted to be president. He 
has promised to repeal Obamacare many times. His most commonly used campaign slogan 
was “repeal and replace Obamacare”.  
On the other hand, Trump’s major Democratic presidential contender, Senator Clinton 
supported retaining and expanding the ACA and would make health insurance enrollment 
easier through the law. In the meantime, she would fix the things which did not work in the 
ACA. In a nutshell, she would "save what works" about the ACA and tame its rising costs. In 
summary, Clinton’s position on the ACA was to save and improve it.  
In this study, we examine the health care industry stock returns associated with the 2016 
presidential campaign. We examine in detail the impacts of important political events on the 
returns of health care stocks. Because the presidential campaign was a long and fluid process, 
we carefully identify the events. Also, the health care industry is very diverse, representing a 
broad range of sectors. Those diverse sectors would not be affected uniformly. We 
hypothesize and identify which sectors would benefit or lose under each event. Then, we use 
event study methodologies to document the abnormal stock returns of each health care sector 
associated with each event.  
Our paper is organized as follows. In Section 2, we review the opposing views on the ACA 
and develop our hypotheses. We explain our research design and methodologies in Section 3. 
The empirical results are presented and discussed in Section 4. We present conclusions in 
Section 5. 
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2. Opposing Views on the ACA  
The ACA has three important aspects. The centerpiece of the ACA is the individual mandate 
which is supported by the employer mandate and the exchanges i.e., marketplaces. The 
individual mandate requires most Americans to have health insurance or pay a penalty when 
they file their federal income tax return. Individuals must have "minimal essential coverage," 
which includes: coverage under an employer-sponsored plan, coverage under an individual 
insurance policy, coverage under a government-sponsored plan such as Medicare or Medicaid 
or U.S.-issued expatriate insurance coverage (IRS, 2018). The main rationale for the 
individual mandate is to prevent the "adverse selection” problem; those who are healthy and 
believe that they will remain so won’t buy insurance while those who are sick or think they 
may become so will buy insurance.  
Although the main goal of the individual mandate was to preempt the adverse selection 
problem, it made the situation no better than before. Many young adults find that it was 
financially advantageous for them to forgo health insurance, pay the moderate mandate 
penalty, and personally cover their own health care expenses. While this would leave them 
vulnerable to extremely high medical bills if they endured a catastrophic illness or accident, it 
created big challenges for the ACA in its push to enroll the young adults. Those young adults 
who had remained under the radar of the individual mandate were coined “young 
invincibles”. 
The second major aspect of the ACA was the employer mandate. The employer mandate or 
employer penalty required that employers of more than fifty full-time employees must either 
provide health insurance for full-time employees or pay a penalty for not doing so. The 
mandate or penalty was intended, of course, to encourage employers to provide health 
insurance. 
The third aspect of the ACA was the exchanges. The exchanges or market-places were where 
people could purchase health insurance from participating insurance companies. They were 
also where the major government assistance was provided. Those who purchase insurance in 
an exchange typically receive a tax credit. The ACA prohibited insurers from denying access 
to coverage based on pre-existing conditions and prohibited them from charging different 
premiums to individuals based on their health. Everyone was in one big insurance pool, 
sharing in the average cost in the same exchange. 
To keep premiums affordable, it was vital that the law attract a substantial number of young 
and healthy “invincibles”. They were less likely to need critical care to balance out older and 
sicker uninsured people who enrolled and would be costlier to the system. However, critics of 
the ACA argued that the insurance pool system exacerbated the adverse selection problem, 
raised the average cost of doing business for insurers, and led them to raise premiums on 
everyone. That, in turn, could cause even more healthy young people to drop insurance 
because they no longer saw it as good value, again requiring insurers to increase premiums, 
and so on, resulting in a “death spiral.” 
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Indeed, the Department of Health and Human Services (HHS) reported in early January 2014 
that 24 percent of Obamacare’s enrollees were young people (Kliff, 2014). According to 
George Mason University’s Mercatus Center, the figures remained at 36 percent in both 2015 
and 2016. It was better than the figure in 2014, but still were way below the initial weighted 
projection for 2015 and 2016 of 47 percent. The lack of incentives for young, healthy, and 
therefore cheap-to-insure individuals to sign up for coverage and the possibility that coverage 
may not be affordable enough for the previously uninsured to enroll became the hallmarks of 
the reform’s complexity and its problems. 
Since the makeup of the Obamacare risk pools, i.e., the balance of healthy and sick 
participants in a plan, was sicker and costlier than insurers hoped, most insurance companies, 
therefore, had experienced losses in the exchanges, often large losses.
 
It only made sense that 
most exchange insurers would request significant rate increases. Should regulators reject 
large premium increases, participating insurance companies could simply decide to cut their 
losses and drop off the exchanges altogether. In 2016, eight states had Obamacare plans 
whose premiums increased by at 30% or more (Tuttle, 2016).  
Even with large premium increases, insurance companies still suffered almost $2 
billion in losses in 2016 according to Bloomberg Business Week’s August 17, 2016 
report. Initially, they scaled back their presences in some states. Eventually, the two 
largest insurance companies, UnitedHealth and Aetna, announced in 2016 that they 
would pull out from most exchanges in 2017.  
Thus, with all those issues, the ACA became a controversial and hot button campaign topic. 
Both candidates had tried to score points with voters by offering their opinions and solutions 
of dealing with the ACA. Candidate Clinton had made the ACA the centerpiece of her health 
care plan. She embraced the law and promised to defend and expand it. Her plan to expand 
Obamacare consisted of a slew of incremental measures that together were intended to cut 
costs and improve coverage for patients. On the other hand, Trump believed that the ACA 
was totally broken. It could not be fixed, and repeal was the only fix. Here was one of his 
typical remarks on the ACA - “Completely repeal Obamacare. Our elected representatives 
must eliminate the individual mandate. No person should be required to buy insurance unless 
he or she wants to”.  
3. Literature Review and the Impact of the ACA on Stock Returns 
3.1 Literature Review 
Beginning with the seminal paper of Fama et al. (1969), researchers have applied event study 
methodology to study the effect of policy changes, not only in this country, but in many other 
countries. Since the literature on event study is voluminous, we focus our attention, in this 
study, on the literature of using event study methodology to examine recent changes in health 
care policies and practices.  
Topping, Carroll, and Lindley (1997) examine the response of hospital stocks to the Medicare 
Prospective Payment System (PPS) legislation and its resulting effect on the ability of 
hospitals to generate funds for expansion and growth. They find that hospital stocks react 
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negatively to PPS legislation. This result lends credence to qualitative evidence showing that 
hospitals' capital positions are impaired because of the PPS legislation; i.e., hospitals’ profit 
margins fall, bond ratings drop, borrowing costs increase; the rate of hospital bond defaults 
increase and capital improvements are delayed (Topping et al., 1997).  
Several studies have used event study methodology to examine the impact of the passage and 
Supreme Court upholding of the ACA on health care industry stock prices. Al-Ississ and 
Miller (2013) use the surprise election of Republican Scott Brown to the U.S. Senate to 
examine the ACA’s impact on the health care industry. Their paper shows a strong 
association between Scott Brown’s victory and positive abnormal returns for firms in the 
healthcare sector, particularly in the health insurance and pharmaceutical sectors.  
Bell (2011) uses prediction markets, i.e., Public Option Contract and the Obamacare Contract, 
to examine Obamacare. Evidence from the Obamacare Contract suggests that the winners of 
the reform effort are health care facilities (hospitals), managed care firms, and brand 
pharmaceuticals, while medical device distributors, health services, and generic 
pharmaceuticals are losers. 
Hartley (2012) examines the effect of this Supreme Court ruling. He focuses on firms within 
different health care sectors (managed care, biotech, hospitals, health care services, and 
pharmaceuticals). Specifically, he finds significantly negative abnormal return for managed 
care and biotechnology stocks, but significantly positive abnormal returns for hospitals and 
health care services stocks. In addition, Ababneh and Tang (2013) find that the law has a 
negative effect on health insurance companies, and on generic drug makers. On the other 
hand, it has a positive effect on hospitals and on brand-name drug makers.  
Dong (2014) investigates the effect of the Congress’s passage of the ACA in 2010 and the 
Supreme Court’s upholding of the Act in 2012 on the stock returns of health care firms. He 
finds that the 2-day (-1, 0) cumulative abnormal returns (CARs) are significantly positive for 
hospitals on both events, and the CARs are also significant for doctor clinics on the passage 
day and specialty outpatient facilities on the upholding day. None of the other sectors have 
significant CARs. 
Borochin and Golec (2016) use both the stock and option markets to investigate the House of 
Representatives passage of the ACA and the subsequent Supreme Court ruling on the ACA’s 
constitutionality. They find that the passage of the ACA and the Supreme Court ruling have 
significant and positive net effects on the hospital and health insurance industries, but not the 
pharmaceutical industry.  
Blau et al. (2016) find that the passage of the ACA has a negative effect on health insurance 
companies and medical device companies, while having a positive influence on firms in the 
health care sector. Topping et al. (2018) examine the impact of Supreme Court’s upholding of 
the ACA on insurance stocks. Their results provide weak support for a negative market 
reaction hypothesis, with returns among insurers varying significantly. We summarize the 
results documented from the above studies in Table 1. 
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Table 1. Summary of event studies on the impact of the ACA 
 Proposing/Passing of the 
ACA 
Upholding of the ACA by 
the Supreme Court 
Ababneh and Tang (2013) Winners: hospitals and brand 
pharmaceuticals  
Losers: insurers and generic 
pharmaceuticals 
 




pharmaceutical firms and 




 Winners: health care 
facilities (hospitals), 
managed care firms, and 
brand pharmaceuticals  
Losers: medical device 
distributors, health 




 Winners: hospitals and 
health care services stocks 
Losers: managed care and 
biotechnology stocks  




Borochin and Golec (2016)
 
Winners: hospitals  Winners: hospitals 
Losers: insurers 
Blau et al. (2016)
 
Winners: health care 
providers 
Losers: insurers, device 
companies 
 
Hilliard et al. (2018)
 
 Losers: insurers 
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There is an ongoing debate on the effectiveness of the ACA. Geyman (2015) compares the 
goals of the ACA to the achievements attained and argue that health care costs are still on the 
rise with its containment becoming more challenging. However, Hall and McCue (2016) 
believe that the ACA could improve health insurance pricing in the foreseeable future. In 
their article, they discuss how the ACA has transformed the financial performance of health 
insurance companies. They argue that a quarter of insurers performed worse than others, 
especially in the first full year of the reform, but that costs can be manageable down the line.  
3.2 Impact of the 2016 Election on Health Care Stocks 
When we look at the totality of the evidence presented in Table 1, it appears that the ACA 
benefits the hospital and health care services stocks and hurts the health insurance stocks. 
There is some evidence that the law also hurts the pharmaceutical, biotechnology, and 
medical device firms. For the other health care stocks, the evidence is not conclusive.  
Based upon the summary presented in the table, we conjecture that any 2016 presidential 
campaign events favoring Clinton would be good for the winners of the ACA, and bad for the 
losers of the ACA. On the other hand, any campaign event favoring candidate Trump would 
be bad for the winners of the ACA and good for the losers of the ACA.  
Most of the studies we review focus on one or two events: The passage of the ACA in the 
House and the Supreme Court’s upholding of the law. Our study, instead, examines the 
impact of a series of 2016 presidential election events on various health care sectors. The 
events include the dates that Clinton and Trump declared their candidacies, the dates they 
became the presumptive candidates of the Democratic and Republican parties, and the day 
after the election. 
4. Research Design 
4.1 Data Collection 
The sample period starts from April 12, 2015, when Clinton announced her candidacy to 
March 24, 2017, when the American Health Care Act of (AHCA) was withdrawn from the 
House. The event dates for this study are retrieved and cross examined from various news 
agencies such as Dow Jones, Reuters, New York Times, CNN, Fox News, etc. We present a 
summary of the event dates in Table 2. 
Table 2. Chronicle of 2016 presidential election selected events 
Event Date 
Hillary Clinton announced her candidacy 4/12/2015 
Donald Trump announced his candidacy 6/16/2015 
Donald Trump became Republicans’ presumptive candidate 5/4/2016 
International Journal of Accounting and Financial Reporting 
ISSN 2162-3082 
2019, Vol. 9, No. 4 
http://ijafr.macrothink.org 267 
Hillary Clinton became Democrats’ presumptive candidate 6/7/2016 
Donald Trump won the presidential election 11/9/2016 
We employ an archival research design to assess the market impact of five significant events 
from the candidacy announcement to the day after the election. We first retrieve a list of all 
health care companies from NASDAQ company list. The list of company names and ticker 
symbols is used to identify Cusip from Compustat. The resulting list is then used to access 
the Permno for the companies from CRSP to enable data analyses on Eventus. There are 
twelve health care sectors according to the NASDAQ classification.  
Out of the twelve sectors, we select five major sectors according to the following criteria: the 
number of firms in the sectors, representativeness of the sectors, and the relevance of the 
sectors in literature. Based on these classifications, the sectors selected are the Biological 
Products (BIO, 36 firms), Health Insurance (INS, 6 firms) Hospital/Nursing Management 
(HOS, 12 firms), Major Pharmaceuticals (PHA, 148 firms), Medical/Dental Instruments 
(MED, 35 firms).  
4.2 Methodologies 
In this study, we use two methodologies to measure the impacts of the five events on the five 
health care sectors’ stock returns: Market model methodology and the seemingly unrelated 
regression (SUR) methodology. 
4.2.1 Market Model Methodology  
The abnormal returns are measured using the Brown and Warner (1985) market model. The 
market model has been widely used in event studies and is defined as: 
                           (1) 
Where Rit is the rate of return of the common stock of security i on day t, and Rmt is the rate 
of return on an equally-weighted market index on day t. The  and  are ordinary least 
squares estimates of  and . We estimate the OLS parameters using a common 100-day 
estimation period. The abnormal returns are measured over three window periods: -5 to -1, 0 
to +1, and +2 to +5. We use Eventus to facilitate our computation of market model abnormal 
returns and Z statistics to assess the statistical significance of the abnormal returns. 
4.2.2 Seemingly Unrelated Regression (SUR) Methodology 
To check for robustness, we also estimate the abnormal returns using seemingly unrelated 
regression (SUR) methodology. Similar to the methodology used by Schipper and Thompson 
(2014), SUR considers the contemporaneous dependence of disturbances. Therefore, the use 
of SUR will yield more efficient estimates relative to the standard event study methodology 
),ˆˆ( mtiiitit RRA  
i̂ i̂
i i
International Journal of Accounting and Financial Reporting 
ISSN 2162-3082 
2019, Vol. 9, No. 4 
http://ijafr.macrothink.org 268 
that requires residuals to be identically and independently distributed (Nguyen and Tang, 
2011).  
4.2.3 Regression Analysis 
We estimate the following regression model: 
CAR = β0 + β1BIO + β2INS + β3HOS + β4PHA + β5FM_SZ + β6MTB + β7LEV 
+ β8ROA + β9CS_TA + β10RD_TA                                        (2) 





, 2016. BIO is a dummy variable that takes the value of one for firms that operate in 
the BIO Product sector, otherwise zero. INS is a dummy variable that takes the value of one 
for firms that operate in the INS sector, otherwise zero. HOS is a dummy variable that equals 
one for firms that operate in the HOS sector, otherwise zero. PHA is a dummy variable that 
equals one for firms that operate in the PHA sector, otherwise zero.  
We also include relevant control variables in the model. FM_SZ is firm size, estimated as the 
natural logarithm of total assets. We expect the larger health care firms will be affected more 
on the post-election day. MTB is market to book value. It is computed as the ratio of market 
value of equity to book value of assets. Because it is a measure of a firm’s growth 
opportunity, we expect firms with higher MTB will be affected more on the post-election 
day.  
LEV represents leverage, the ratio of debt to total assets. ROA is the ratio of earnings before 
interest and tax to total assets. We don’t make predictions on the sign of these two control 
variables. CS_TA is the ratio of capital expenditure to total assets and RD_TA is the ratio of 
research and expenditure to total assets. We expect the sign of these two variables will go in 
the same direction of the post-election two-day CAR. 
5. Results 
5.1 Event Study Results 
We examine the events in several periods: -5 to -1, 0 to +1 and +2 to +5. Examining the 
period of -5 to -1 detects whether there is any pre-reaction to the event. The next period is 
normally used in the event study literature to investigate market reactions; the last period, +2 
to +5, is to examine if there are any post-event adjustments. We first use market model 
methodology to carry out the event study and present the results in Table 3. We then use SUR 
to confirm our market model results and present the results in Table 4.  
5.1.1 Clinton's Candidacy Announcement  
In the period of -5 to -1, BIO has significantly positive CAAR. On the other hand, the INS has 
significantly negative CAAR. None of the other three sectors have significant CAAR. In the 
two-day announcement period of 0 and +1, the INS continues to have significantly negative 
CAAR.  
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In the post-event period of +2 to +5, other than the HOS, all other four sectors suffer 
significantly negative CAARs. It appears that the investors take a pretty dim view on the 
overall health care industry associated with this event. 
The SUR event study results for the periods -5 to -1 and +2 to +5 do not suggest any significant 
abnormal returns. However, in the period of 0 and +1, the SUR result for the PHA is 
significantly positive. 
5.1.2 Trump's Candidacy Announcement  
In the period of -5 to -1, both the INS and HOS have significantly positive CAARs. On the 
other hand, PHA has a significantly negative CAAR. In the announcement period of 0 and 1, 
PHA has significantly negative CAAR. The MED has mild and positive CAAR. During the 
post-announcement period of +2 to +5, BIO continues to have significantly negative CAAR. 
On the other hand, PHA has positive CAAR along with MED. It seems that there are no clear 
winners or losers associated with this event. Very likely, the stock market doesn’t think Trump 
is a serious contender at this early stage of the Presidential campaign. 
The magnitudes of the SUR returns are similar to those discussed above. For the periods -5 to 
-1 and 0 to +1, MED has significantly negative CAARs. 
5.1.3 Trump’s Presumptive Nomination 
In the period of -5 to -1, BIO, INS, and PHA all have significantly negative CAARs, at least, at 
the 0.10 significance level. In the event period of 0 and +1, the same three sectors continue to 
have significantly negative CAARs. On the other hand, MED has a significant CAAR of 
0.67%.  
In the period of +2 to +5, PHA continues to have significantly negative CAAR. It appears that 
the BIO, INS, and PHA all fare poorly during this event; especially PHA. There could be two 
different interpretations. First, investors expect that these sectors will suffer if Trump becomes 
the President. Second, Trump is expected not to beat Clinton and these sectors will suffer under 
the Clinton administration. We will have a better understanding about which interpretation 
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Table 3. Market model results 
 
Table 4. SUR results 
 
For the SUR results, in the period of -5 to -1, INS and PHA record significantly negative 
CAARs. The BIO and PHA record significantly negative CAARs in the announcement period 
of 0 and 1. Finally, in the period of +2 and +5, PHA and MED significantly negative CAARs. 
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5.1.4 Clinton’s Presumptive Nomination 
During the pre-event period of -5 to -1, the PHA has significantly negative CAAR. During the 
announcement period, the BIO and PHA have significantly negative CAARs. The HOS has 
significantly positive CAAR. During the post-event period, the HOS and PHA have 
significantly negative CAARs. The MED has significantly positive CAARs. 
In a nutshell, PHA consistently suffers before, during, and after this event. When we look at the 
combined evidence associated with the presumptive nominations of both candidates, it appears 
that the market believes Clinton will win the race and the biggest loser will be PHA. The 
second one will be the BIO.  
The SUR event study results do not suggest any significant abnormal returns, for the most part. 
However, the PHA has a significantly positive CAAR in the pre-event period; the BIO has a 
significantly negative CAAR during the announcement period, similar to the market model 
result; and in the post-event period, the MED has a significantly negative CAAR. 
5.1.5 Trump Wins the Election 
During the immediate pre-election period, all major headline news lopsidedly predict that 
Clinton will win the election. Based upon our previous predictions, a sector such as HOS is 
likely to be the over performer in the pre-election period of -5 to -1. PHA and BIO are more 
likely to be the underperformers in this period. When the election results are revealed, the 
opposite will happen; PHA and BIO are the over-performers and HOS is likely to be the 
underperformer. 
Our findings associated with this event, in general, support our prediction. We find that in the 
pre-event period of -5 to -1, BIO and HOS have significantly positive CAAR. The PHA has a 
negative CAAR, although not significant. During the event period, the BIO and the PHA have 
significantly positive CAARs. But HOS has significantly negative CAAR. During the period 
of +2 to +5, there is a certain degree of reversal effect; Both BIO and PHA have significantly 
negative CAARs. SUR results are similar to the market model results discussed above.  
5.1.6 Summary of Our CAAR Findings 
When we consider all the events together, a clear pattern appears. During the pre-election 
period, the BIO, INS, and PHA all suffer significantly negative CAARs. The HOS and MED 
fare reasonably well. Our interpretation is that the market takes a dim view on BIO, INS, and 
PHA when the consensus is that Trump stands no chance against Clinton. Clinton will win the 
election and Obamacare will continue under her administration. The status quo will be harmful 
for these three health care sectors.  
When the election is over, the unthinkable happens. Investors immediately reassess the impact 
of the election. The fortune reverses for the BIO and PHA. 
5.2 Regression Analysis Results 
We present our regression results of estimating Model (2) in Table 5. The results show that the 
signs of both BIO and PHA are significantly positive. The magnitudes of the coefficients, 
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0.056 and 0.061, for BIO and PHA are similar to each other. Both are significant at the 0.01 
significance level. The coefficients of the other two indicator variables, INS and HOS, are not 
significant. These results confirm our CAAR results. On the post-election day, BIO and PHA 
are the clear winners among five health care sectors.  
Table 5. Multivariate regression results on the following model  
CAR = β0 + β1BIO + β2INS + β3HOS + β4PHA + β5FM_SZ + β6MTB + β7LEV 
+ β8ROA + β9CS_TA + β10RD_TA                                    
Estimation of Regression Model (F =4.07, P < 0.0001, Adjusted R
2
 = 0.115) 
Variable Predicted Sign Parameter Standard Pr > |t| 
   Estimate Error   
Intercept  -0.06014 0.02843 0.0355 
BIO + 0.05632*** 0.02143 0.0092 
INS + -0.03517 0.04082 0.3898 
HOS - -0.01393 0.03073 0.6508 
PHA + 0.06067*** 0.01708 0.0005 
FM_SZ + 0.0103 0.00867 0.2359 
MTB + 0.00388* 0.00207 0.0619 
LEV + 0.01448 0.01584 0.3615 
ROA - -0.01945 0.02189 0.3752 
CS_TA + 0.03724 0.0243 0.1268 
RD_TA + -0.01798 0.03882 0.6436 
***, **, and * denotes significant p-value at 1%, 5%, and 10%. The dependent variable is 
CAR, the cumulative abnormal returns over the event window [0,1]. The event date is 
November 9, 2016, the day of the elections. The main dependent variables are winners when 
the Affordable Healthcare Act is saved or improved and winners when the Affordable 
Healthcare Act (ACA) is repealed. Definition of variables are as follows: WINSAV, a 
dummy variable that equals one for firms that are winners when the ACA is saved or 
improved, zero otherwise. These are companies that operates in the hospital or nursing 
management industry. WINREP, a dummy variable that equals one for firms that are winners 
when the ACA is repealed, zero otherwise. These are companies that operates in the 
Biological Products, Health Insurance, Major Pharmaceutical, and Medical and dental 
products industries. BIO is a dummy variable that takes the value of one for firms that 
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operate in the biological Product industry, otherwise zero. INS denotes a dummy variable that 
takes the value of one for firms that operate in the health insurance industry, otherwise zero. 
HOS is a dummy variable that equals one for firms that operate in the hospital or nursing 
management industry, otherwise zero. PHA is a dummy variable that equals one for firms 
that operate in the major pharmaceutical industry, otherwise zero. MED refers to a dummy 
variable that takes the value of one for firms that operate in the medical and dentist products 
industry, otherwise zero. FM_SZ is firm size, estimated as the natural logarithm of total 
assets. MTB is market to book value. It is computed as the ratio of market value of equity to 
book value of assets. LEV represents leverage, the ratio of debt to total assets. ROA is the 
ratio of earnings before interest and tax to total assets. CS_TA is the ratio of capital 
expenditure to total assets and RD_TA is the ratio of Research and expenditure to total assets.  
Among the control variables, MTB is significantly positive at the 0.1 level. This is consistent 
with our earlier prediction that health care firms with higher MTB benefit more on the 
post-election days of 0 and +1. None of the other control variables is significant. 
6. Conclusions 
The future of the ACA was one of the most contentious issues during the 2016 Presidential 
Campaign. The two candidates’ positions on the issue were in sharp contrast with each other. 
On one hand, the Democratic candidate Clinton held the position that it could be improved. 
She would like to save and improve it. On the other hand, the Republican candidate Trump 
firmly believed that the ACA was totally broken. He wanted to repeal and replace it. 
In this study, we survey the literature and document what the five major health care sectors 
experienced when the ACA was signed into law and when it was upheld in the Supreme court 
during the Obama administration. We find that HOS the winner of the ACA and INS, PHA, 
and BIO are the losers under the ACA. We conjecture, by way of extrapolation, that any 2016 
presidential campaign event favoring Clinton would be good for the HOS and bad for the INS, 
PHA, and BIO sectors. However, any campaign event favoring candidate Trump would be 
bad for HOS, but good for INS, PHA, and BIO sectors.  
We identify five important events during the 2016 Presidential campaign and examine the 
stock reactions of these five sectors pre-, during, and post-event abnormal returns. We first 
use the traditional market model regression and then the SUR regression to estimate the 
abnormal returns. It is not surprising that these two methods give us consistent results.  
We find that, during the pre-election period, the BIO, INS, and PHA all suffer significantly 
negative CAARs. The HOS and MED fare reasonably well. Our interpretation is that the 
market takes a dim view on the BIO, INS, and PHA sectors when the consensus is that 
Clinton would win the election. The status quo would be harmful for these three healthcare 
sectors. When the election is over, the fortune reverses for the BIO and PHA. The regression 
results further confirm our event study results. 
There are several important take-aways from this study. First, the election has a significant 
impact on the affected industry and the sectors/firms in the industry. However, even in the 
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same broad industry, sectors/ firms fare differently. It is important to examine the impact of a 
policy in a more detailed and refined way.  
Second, the stock market reacts expeditiously to expectations. In most of these events, we 
find that the abnormal returns are significantly positive for the sectors which will benefit 
from Clinton’s presidency and negative for the sector which will be disadvantaged during the 
pre-election events. When the election is over, the investors immediately reassess the 
prospects of the health care sectors and react accordingly.  
Thirdly, we use the findings from extant studies on the impact of the ACA on the health care 
firms to extrapolate our predictions. It appears that the evidence presented in this study is 
very consistent with our predictions. This could be a shortcut yet adequate way of articulating 
the hypotheses/ predictions in similar studies.  
The ACA is one of the most contentious issue that is at the forefront of public policy debate 
in the US, and it continues to face challenges with respect to its implementation. Questions 
still exist as to whether the ACA should be completely replaced with a market-oriented 
reform or if it should just be revised. In this paper, we focus only on the five major health 
care sectors in the US. Hence, our results cannot be generalized to other sectors within the 
health insurance system. Future research can examine and compare the ACA to other health 
care legislations of countries with low-cost and effective healthcare systems. More research is 
also needed to understand and determine the optimal role of the government in healthcare.  
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